Enovix Statistics
Total Valuation
Enovix has a market cap or net worth of $1.40 billion. The enterprise value is $1.48 billion.
Important Dates
The next estimated earnings date is Wednesday, May 6, 2026, after market close.
| Earnings Date | May 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Enovix has 211.79 million shares outstanding. The number of shares has increased by 11.61% in one year.
| Current Share Class | 211.79M |
| Shares Outstanding | 211.79M |
| Shares Change (YoY) | +11.61% |
| Shares Change (QoQ) | +4.59% |
| Owned by Insiders (%) | 11.29% |
| Owned by Institutions (%) | 52.40% |
| Float | 187.88M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 45.46 |
| Forward PS | 34.86 |
| PB Ratio | 5.32 |
| P/TBV Ratio | 6.36 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 46.47 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.34, with a Debt / Equity ratio of 1.99.
| Current Ratio | 8.34 |
| Quick Ratio | 7.94 |
| Debt / Equity | 1.99 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -8.17 |
Financial Efficiency
Return on equity (ROE) is -59.84% and return on invested capital (ROIC) is -17.51%.
| Return on Equity (ROE) | -59.84% |
| Return on Assets (ROA) | -15.69% |
| Return on Invested Capital (ROIC) | -17.51% |
| Return on Capital Employed (ROCE) | -21.69% |
| Weighted Average Cost of Capital (WACC) | 12.56% |
| Revenue Per Employee | $47,923 |
| Profits Per Employee | -$236,056 |
| Employee Count | 664 |
| Asset Turnover | 0.05 |
| Inventory Turnover | 2.42 |
Taxes
| Income Tax | -1.31M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +6.49% in the last 52 weeks. The beta is 2.16, so Enovix's price volatility has been higher than the market average.
| Beta (5Y) | 2.16 |
| 52-Week Price Change | +6.49% |
| 50-Day Moving Average | 5.58 |
| 200-Day Moving Average | 8.90 |
| Relative Strength Index (RSI) | 62.26 |
| Average Volume (20 Days) | 5,710,922 |
Short Selling Information
The latest short interest is 55.11 million, so 26.02% of the outstanding shares have been sold short.
| Short Interest | 55.11M |
| Short Previous Month | 58.24M |
| Short % of Shares Out | 26.02% |
| Short % of Float | 29.33% |
| Short Ratio (days to cover) | 9.47 |
Income Statement
In the last 12 months, Enovix had revenue of $31.82 million and -$156.74 million in losses. Loss per share was -$0.75.
| Revenue | 31.82M |
| Gross Profit | 6.11M |
| Operating Income | -176.55M |
| Pretax Income | -157.92M |
| Net Income | -156.74M |
| EBITDA | -141.44M |
| EBIT | -176.55M |
| Loss Per Share | -$0.75 |
Full Income StatementBalance Sheet
The company has $512.04 million in cash and $544.29 million in debt, with a net cash position of -$32.25 million or -$0.15 per share.
| Cash & Cash Equivalents | 512.04M |
| Total Debt | 544.29M |
| Net Cash | -32.25M |
| Net Cash Per Share | -$0.15 |
| Equity (Book Value) | 274.01M |
| Book Value Per Share | 1.28 |
| Working Capital | 477.19M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$95.29 million and capital expenditures -$18.22 million, giving a free cash flow of -$113.51 million.
| Operating Cash Flow | -95.29M |
| Capital Expenditures | -18.22M |
| Depreciation & Amortization | 35.11M |
| Net Borrowing | 359.08M |
| Free Cash Flow | -113.51M |
| FCF Per Share | -$0.54 |
Full Cash Flow StatementMargins
| Gross Margin | 19.19% |
| Operating Margin | -554.83% |
| Pretax Margin | -496.27% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Enovix does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -11.61% |
| Shareholder Yield | -11.61% |
| Earnings Yield | -10.84% |
| FCF Yield | -7.85% |
Analyst Forecast
The average price target for Enovix is $13.61, which is 105.59% higher than the current price. The consensus rating is "Buy".
| Price Target | $13.61 |
| Price Target Difference | 105.59% |
| Analyst Consensus | Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (5Y) | 138.72% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Enovix has an Altman Z-Score of 0.35 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.35 |
| Piotroski F-Score | 4 |
